Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide

Trial Profile

Correlation Between Serum Vitamin D Levels and the Incidence of Peripheral Neuropathy Among Multiple Myeloma Patients Who Have Previously Received Treatment With Bortezomib or Thalidomide

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Mar 2016

At a glance

  • Drugs Bortezomib (Primary) ; Thalidomide (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions
  • Sponsors Biomira USA
  • Most Recent Events

    • 08 Mar 2016 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 10 Apr 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2014 to 1 Apr 2016.
    • 10 Apr 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Sep 2014 to 1 Apr 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top